Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Proposal To Improve Patient Information Attracts More EU Support

This article was originally published in The Pink Sheet Daily

Executive Summary

Pharma is relieved as an EU parliamentary committee approves revised information-to-patients proposals

You may also be interested in...

EFPIA Urges Drug Makers To See Value In Mobile Apps

The head of EFPIA believes drug makers are squandering opportunities offered by mobile health applications, a key point in the European trade body’s new manifesto.

Drug Development Must Be Patient-Centric; Adherence Schemes Must Follow

Global health systems are losing billions of dollars by not introducing schemes to tackle drug adherence, but are heading in the right direction with patient-centric drug development.

Lacking "Mediator," EC Tightens Pharmacovigilance Proposals

European Commission's surprise update of the pharmacovigilance rules is included in its review of the information to patients legislation, but industry's biggest concern may be the failure to address the role of social media.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts